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Abstract – To improve the understanding of the dynamics and options for control of classical swine fever
(CSF), more quantitative knowledge is needed on virus transmission. In this study, virus excretion and
within-pen transmission of a strain of low, moderate and high virulence were quantiﬁed. Furthermore, the
effect of inoculation dose on excretion and transmission were studied. The transmission was quantiﬁed
using a stochastic susceptible-exposed-infectious-recovered (SEIR) model. Five transmission trials were
conducted with ten pigs each. In each trial, three pigs were inoculated with the low virulent strain Zoelen, a
low (102 TCID50), middle (10
3.5 TCID50), or high dose (10
5 TCID50) of the moderately virulent strain
Paderborn, or the highly virulent strain Brescia. The other seven pigs in each trial served as contact pigs.
None of the pigs inoculated with the low dose of the Paderborn strain were infected. When it was assumed
that the infectiousness of the pigs coincided with virus isolation positive oropharyngeal ﬂuid and/or faeces,
no signiﬁcant differences in transmission rate b and basic reproduction ratio R0 between the high
inoculation dose of the Paderborn strain (b = 1.62/day, R0 = 35.9) and the Brescia strain (b = 2.07/day,
R0 = 17.5) were observed. When the middle dose of the Paderborn strain was used for inoculation, the b
(5.38/day) was not signiﬁcantly higher than the Brescia strain or the high inoculation dose of the Paderborn
strain, but the R0 (148) was signiﬁcantly higher. Infection with the Zoelen strain resulted in a signiﬁcantly
lower b and R0 (b = 0/day, R0 = 0) than the other strains.
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1. INTRODUCTION
Classical swine fever (CSF) is a highly con-
tagious viral disease that affects domestic pigs
and wild boar. For many European countries
with a non-vaccination policy this is an exotic
disease, but outbreaks occur occasionally. In
areas with a high pig density, this has resulted
in severe economic losses due to mass destruc-
tion of pigs and export limitations [16].
Classical swine fever virus (CSFV) is
excreted by infected pigs in saliva, nasal and
lacrimal ﬂuids, faeces and urine [19, 28].
Infected pigs can transmit the virus to suscepti-
ble pigs via these secretions and excretions.
This can occur by direct contact, or indirectly
via contaminated clothes, livestock trucks,
buildings or fomites [20, 21]. The efﬁciency
and speed of transmission are dependent on
several underlying parameters. For one, this
includes the amounts of infectious virus
excreted by infected pigs in their secretions
and excretions, which may in turn depend on* Corresponding author: eefke.weesendorp@wur.nl
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age and breed of the pigs, virus strain, inocula-
tion dose or immune status. Additional impor-
tant parameters include contact structure
between infectious and susceptible pigs, sur-
vival of virus in the environment and the sus-
ceptibility of contact pigs.
Direct transmission can be studied in trans-
mission experiments where a number of pigs
is inoculated with the virus and subsequently
virus transmission to contact pigs within the
same pen is studied [4]. The transmission rate
b and the basic reproduction ratio (R0) can then
be used to quantify the transmission. The trans-
mission rate b is deﬁned as the number of sec-
ondary infections caused by one infectious
individual per unit of time. The R0 is deﬁned
as the average number of secondary infections
caused by one infectious individual during its
entire infectious period in a fully susceptible
population. If R0 is smaller than 1, the infection
within the population will fade out. If the R0 is
greater than 1, a large outbreak can occur. The
b and R0 can be estimated using a susceptible-
exposed-infected-recovered (SEIR) model [7,
11]. This model describes the transmission
dynamics by the change in the number of sus-
ceptible pigs (S), the number of pigs that are
infected but not yet infectious (E), the number
of infectious pigs (I), and the number of pigs
that recovered or died (R) per unit of time. This
requires assumptions regarding the start and
duration of the infectious period of infected ani-
mals and the moment of infection of contact
pigs. In previous studies, mostly viraemia was
used to determine this1 [8, 13–15]. The main
problem with viraemia is that the virus is iso-
lated from a site from which it cannot be trans-
mitted to other pigs, and viraemia does not
necessarily coincide with virus excretion in
secretions and excretions [28]. Furthermore,
for the determination of the moment of infec-
tion of contact pigs, viraemia does not seem
to be the most biologically appropriate measure,
since the virus replicates ﬁrst in the tonsil and
pharyngeal region, after which it can infect
other animals via oronasal secretions. Viraemia
occurs in a later stage of the infection. As a
result, the transmission parameters could be
over- or underestimated.
Previous studies have estimated transmission
parameters, but only limited data was available
on underlying parameters like virus excretion,
and their relation to transmission1 [8, 13]. For
three strains, of either high, moderate or low
virulence, we have detailed information on
excretion dynamics [28]. However, information
on the transmission characteristics of these
strains is limited or lacks accuracy, as described
above. Knowledge on transmission mecha-
nisms is needed to know how transmission
can be reduced during an outbreak. Especially
information on underlying parameters of trans-
mission like virus excretion and their relation
to transmission are needed.
Therefore, we studied the virus excretion
and the within-pen transmission of the same
highly, moderately and low virulent strains, as
we used in the previous study on excretion
dynamics. Moreover, the effect of the inocula-
tion dose on excretion and transmission was
studied, since pigs are infected during outbreaks
with varying doses of virus. We used different
assumptions on infectiousness of pigs to study
the relationship between virus excretion and
transmission.
2. MATERIALS AND METHODS
2.1. Experimental design
Five transmission experiments were carried out
with ten pigs each. Each transmission experiment
was performed in a separate room of an isolation unit.
At the start of the experiment, three pigs were
removed from each group and intranasally inocu-
lated. After 24 h [3, 12, 23], the inoculated pigs were
returned to their original groups, allowing contact
exposure of the remaining seven pigs. Each group
was inoculated with a different virus strain or dose.
The experiment was terminated 35 days post-inocula-
tion (p.i.). This experiment was approved by the
Ethics Committee for Animal Experiments of the
Animal Sciences Group of Wageningen UR.
1 Klinkenberg D., Bouma A., Floegel-Niesmann
G., De Jong M.C.M., E2 subunit marker vaccines
reduce transmission of classical swine fever virus
sufﬁciently to halt epidemics, Ph.D. thesis, Univer-
sity of Utrecht, The Netherlands, 2003, pp. 37–60.
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2.2. Experimental animals
Eight-week-old male pigs were obtained from
a conventional, but pestivirus free pig herd in the
Netherlands, and were randomly divided into the ﬁve
groups. The pigs were fed once a day and had unlim-
ited access to water.
2.3. Viruses and inoculation of animals
In the ﬁrst experiment, three pigs were inoculated
with a dose of 105 TCID50 (50% tissue culture infec-
tious dose) of the low virulent strain Zoelen (geno-
type 2.2), used at cell passage level 3. This strain
was originally isolated during an outbreak on a Dutch
farm. In the second, third and fourth experiment,
three pigs each were inoculated with the moderately
virulent strain Paderborn, with doses of respectively
102 TCID50 (Paderborn low dose), 10
3.5 TCID50
(Paderborn middle dose), and 105 TCID50 (Paderborn
high dose). This strain (genotype 2.1) was isolated in
1997 during the outbreak in the Paderborn area of
Germany [10], and was used at cell passage level
5. In the ﬁfth experiment, three pigs were inoculated
with a dose of 100 LD50 (50% lethal dose), which is
approximately 102.5 TCID50, of the highly virulent
strain Brescia. The virus stock was heparinised blood
from a pig infected with Brescia strain 456610 (geno-
type 1.2). This strain was derived from a strain
obtained in 1951 from Brescia, Italy. The strains were
classiﬁed as low, moderately or highly virulent based
on the classiﬁcation of CSFV strains by Van Oirschot
[25]. One milliliter of the virus suspension was
administered per animal (0.5 mL per nostril). The
inocula were back titrated to conﬁrm the dose
administered.
2.4. Clinical signs and body temperature
Clinical signs and rectal body temperatures were
recorded daily. Fever was deﬁned as a body tempera-
ture higher than 40 C, for two or more consecutive
days. For quantitative assessment of the severity of
disease a list of ten CSF-relevant criteria, as described
byMittelholzer et al. [17] was used. For each criterion
a score was recorded of either normal (score 0),
slightly altered (score 1), distinct clinical symptom
(score 2), or severe CSF symptom (score 3). The
scores for each pig were added up to a total score
per day, with a maximum of 30. Only pigs with total
clinical scores (CS) higher than 2 were deﬁned as pigs
having clinical symptoms due to the CSFV infection.
Sick pigs that became moribund and unable to stand
up were euthanized for reasons of animal welfare.
2.5. Sampling procedures
Serum and EDTA-blood samples were collected
from each pig at days 0, 3, 5, 7, 10, 12, 14, 17, 19,
21, 24, 28, and 35 p.i. Serum samples were stored
at 70 C until testing for antibodies in the ELISA
and NPLA (neutralization peroxidase-linked assay).
EDTA-blood samples were used for immediate leu-
kocyte counts and isolation of leukocytes. For isola-
tion of the leukocytes, 4 mL 0.84% NH4Cl solution
was added to 2 mL of EDTA blood. After 10 min
the samples were centrifuged at 300 g and washed
twice with phosphate-buffered saline (PBS). The pel-
let was resuspended in 2 mL medium (Eagle mini-
mum essential medium (EMEM) with 5% foetal
bovine serum (FBS), and 10% antibiotics solution
ABII (1 000 U/mL Penicillin, 1 mg/mL Streptomy-
cin, 20 lg/mL Fungizone, 500 lg/mL; Polymixin
B, and 10 mg/mL Kanamycin)) and stored at
70 C until analysis in the virus isolation (VI).
Oropharyngeal ﬂuid and faeces were collected at
days 0, 3, 4, 5, 6, 7, 8, 10, 11, 12, 13, 14, 15, 17,
19, 21, 24, 26, 28, 31, 33, and 35 p.i. Oropharyn-
geal ﬂuid was obtained with a gauze tampon held
by a 30 cm long forceps, which was scrubbed
against the dorsal wall of the pharynx behind the
soft palatum. The tampons were not weighed, so
the total amount of oropharyngeal ﬂuid in each tam-
pon was not exactly known, however, based on a
previous experiment the average weight is approxi-
mately 1.0 g (with a standard deviation of 0.4 g)
[28]. The oropharyngeal ﬂuid was suspended in 4
mL of the same media as described for the leuko-
cyte isolation. After centrifugation (1 800 g for
15 min) the samples were stored at 70 C until
analysis in the VI and Real-Time Reverse Transcrip-
tion Polymerase Chain Reaction (RRT-PCR). Faeces
were collected from the rectum by stimulation of the
anus. One gram of faeces was suspended in 9 mL
medium (EMEM containing 10% FBS and 10%
antibiotics solution ABII) and vortexed with glass
beads. After centrifugation (2 500 g for 15 min)
the supernatants were stored at 70 C until analy-
sis in the VI and RRT-PCR.
Tonsils were collected from all pigs during the
post-mortem examination at day 35 p.i., or at an ear-
lier time-point when pigs died or were euthanized for
reasons of animal welfare. From each tonsil 0.1 g
was added to 0.5 mL of medium (same as for isola-
tion of leukocytes), and homogenized in the MagNa
Lyser (Roche Applied Science, Mannheim,
Germany) for 30 s at 3 500 g. After centrifugation
(9 500 g for 1 min), an additional 1 mL of medium
was added. Samples were centrifuged again
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(9 500 g for 5 min) and the supernatant was stored at
70 C until analysis in the RRT-PCR.
2.6. Tests
2.6.1. Leukocyte counts
Leukocyte counts were performed using the Me-
donic CA 620 coulter counter (Boule Medical AB,
Stockholm, Sweden). A decrease in the number of
leukocytes (leukopenia) is a typical sign of CSF
[25]. Leukopenia was deﬁned as < 10 · 109 cells/L
blood [28].
2.6.2. Virus isolation and titration
Presence of infectious virus in the samples was
tested by virus isolation. From oropharyngeal ﬂuid
and faeces, a volume of 250 lL was incubated for
1 h on a monolayer of SK6 cells (permanent porcine
kidney cell line) in a 24-well plate (Corning Incorpo-
rated, Corning, USA) at 37 C in an atmosphere with
5% CO2. Plates were then washed once with PBS
and fresh medium was added to the wells. From leu-
kocyte samples, a volume of 125 lL was directly
incubated on a monolayer of SK6 cells without wash-
ing. Cells were cultured at 37 C in an atmosphere
with 5% CO2. After four days, the growth medium
was discarded, and the monolayers were washed in
a 0.15 M NaCl solution, dried for 1 h at 37 C and
frozen for 1 h at20 C. The monolayers were ﬁxed
with 4% cold (5 C) paraformaldehyde in PBS for
10 min and then washed in 0.15 M NaCl. Monolay-
ers were stained by the immunoperoxidase mono-
layer assay (IPMA) [29], using two horse-radish
peroxidase (HRPO)-conjugated CSFV speciﬁc MAbs
(V3/V4) diluted in PBS (1:4 000) with 4% horse
serum. Monolayers were stained with 300 lL
0.05 M NaAc solution, containing 5% 3-amino-9-
ethyl carbazole (AEC) and 0.05% H2O2, and exam-
ined for stained cells. Virus positive samples were
titrated in four-fold after making ﬁve decimal dilu-
tions. Virus titres were calculated as TCID50 using
the Spearman-Ka¨rber method [9].
2.6.3. RRT-PCR
The presence of viral RNA in oropharyngeal
ﬂuid, faeces and tonsils was analyzed by RRT-
PCR. For RNA isolation, 200 lL of the samples
were pipetted manually into MagNA Pure sample
cartridges (Roche Applied Science). The RNA was
extracted with the Total Nucleic Acid Isolation Kit
(Roche Applied Science) according to the manufac-
turer’s instructions using the automated MagNA Pure
LC instrument (Roche Applied Science). After the
MagNA Pure completed the RNA isolation, the
nucleic acids were removed from the MagNA Pure
LC and immediately processed for the RRT-PCR or
stored at 70 C in the sample cartridge until the
RRT-PCR was carried out.
The RRT-PCR was performed with a LightCycler
(LC) instrument (Roche Applied Science) using the
RNA Master Hybridization Probes Kit, as described
by Van Rijn et al. [26]. Analysis was performed with
the LC software.
2.6.4. Serology (ELISA and NPLA)
The serum samples were tested for antibodies by
the PrioCHECK CSFVAb (Prionics AG, Lelystad,
The Netherlands), an ELISA for detecting CSFV-spe-
ciﬁc (E2) antibodies [1]. The results are expressed as
the percentage inhibition. A cut-off value of 30%
inhibition was applied. Samples with the percentage
of inhibition above 30% were considered positive.
Serum samples were tested in the direct NPLA for
neutralizing antibodies against the homologous
CSFV strains [22]. Serial two-fold dilutions (1:5 to
1:10 240) of serum were mixed with an equal vol-
ume (50 lL) of CSFV (containing 100 TCID50) in
a 96-well plate (Greiner, Frickenhausen, Germany).
After incubation of 1 h at 37 C in an atmosphere
with 5% CO2, 100 lL SK6 cells (approximately
10 000 cells) in medium (Medium Earle’s Balanced
Salts with 0.55% lactalbumin hydrolysate, 1%
MEM vitamin solution (Gibco, Paisley, UK), 5%
FBS, 1% Penstrep (10 000 U/mL Penicillin,
10 000 lg/mL Streptomycin), 1% Fungizone
(250 lg/mL), 1% L-Glutamin (200 mM)) were
added per well. After four days, an IPMA was used
for staining virus positive monolayers. The antibody
titre was then determined as the reciprocal of the
highest two-fold serum dilution that neutralized all
virus.
2.7. Statistical analysis and quantiﬁcation
of transmission parameters
2.7.1. Virus excretion
Differences in virus excretion between the strains
and doses were compared during the ﬁrst days of
virus excretion until the moment contact pigs were
infected. This was in general within 5 days after
the start of virus excretion. Differences in virus
Vet. Res. (2009) 40:59 E. Weesendorp et al.
Page 4 of 14 (page number not for citation purpose)
excretion of the inoculated pigs between strains and
doses were determined by calculating for each
individual inoculated pig the total amounts of virus
excreted in faeces and oropharyngeal ﬂuid (in
TCID50), which was expressed by the cumulative
excretion (against time). Differences between the
strains and doses in mean cumulative virus excretion
(in Log10 TCID50) were statistically analysed using
an analysis of variance (ANOVA) model. Pair wise
comparisons between strains were made using the
Bonferroni method (with an experiment wise Type
I error rate of 0.05). Calculations were performed
with SPSS 12 (SPSS Inc., Chicago, USA).
2.7.2. Estimation of transmission parameters
For the analysis of the transmission, a stochastic
SEIR model was used [7, 11]. In a SEIR model,
the transmission dynamics of infectious diseases
between individuals are described by the change in
the number of susceptible (S), exposed (E), infectious
(I), recovered or removed (dead) (R) and total number
(N) of animals. Assuming that the number of contacts
per animal is independent of the herd size (frequency
dependent mixing) [2], susceptible pigs become
infected with a rate dSt/dt = bÆStÆIt/Nt. In this for-
mula, b is the transmission rate and can be interpreted
as the average number of new infections for a typical
infectious animal in a susceptible population per unit
of time. St is the number of susceptible animals, It is
the number of infectious animals and Nt is the total
number of animals at time t. The probability for a
susceptible animal to become (latently) infected dur-
ing period Dt is P(S ) E) = 1–exp(–bÆItÆDt/Nt), and
the probability for a susceptible animal to escape
infection during a period Dt is given by
P(S ; E) = exp(–bÆItÆDt/Nt). The distribution of the
infectious period is modeled by a beta distribution
with a maximum of 60 days, of which the mean
infectious period Ti and the standard deviation are
estimated from the data. Pigs infected with the strains
used in this study died or recovered in previous stud-
ies before day 60 p.i.1 [28]. The reproduction number
R0 is the expected number of new infections an aver-
age infectious animal causes during its entire infec-
tious period in a fully susceptible population, i.e.
b*Ti. All transmission parameters are estimated by
maximizing their corresponding loglikelihood func-
tions. The 95% conﬁdence intervals are obtained
from the loglikelihood proﬁle, assuming that the log-
likelihood ratio is described by a chi-square distribu-
tion with one degree of freedom.
To estimate b and R0 from the transmission exper-
iments, the moment contact pigs became infected had
to be estimated in a biologically plausible way. In
previous experiments (unpublished data) [28], we
observed the ﬁrst RRT-PCR positive signal in oro-
pharyngeal ﬂuid 1 day p.i. of the highly virulent
strain Brescia and 3 days p.i. of the moderately viru-
lent strain Paderborn and the low virulent strain
Zoelen. For each contact animal, this period (1 or 3
days) was subtracted from the moment the ﬁrst posi-
tive RRT-PCR-signal in oropharyngeal ﬂuid was
observed to obtain the moment of infection.
Furthermore, for the estimation ofb andR0 the start
and end of the infectious period of infected animals
needed tobe determined. The periods of infectiousness
were estimated using three different assumptions.
For the start and end of the infectious period, the
assumption was made that infectiousness had coin-
cided with the following: (1) virus excretion in faeces,
(2) virus excretion in faeces and/or oropharyngeal
ﬂuid, (3) viraemia. Virus excretion and viraemia were
determined by virus isolation. We assumed that any
negative test result both preceded and followed by a
positive test result was false negative.
3. RESULTS
3.1. Infection and transmission
3.1.1. Zoelen
None of the pigs inoculated with the Zoelen
strain showed fever or clinical symptoms, but
infection was conﬁrmed by leukopenia, vira-
emia, serology and RRT-PCR positive tonsils
(Tab. I). Infectious virus, as determined by virus
titration, was detected mainly in oropharyngeal
ﬂuid (Tabs. II and III). No virus transmission to
any of the contact pigs was observed, since no
fever, leukopenia, viraemia, and antibodies
were detected. The virus isolation and RRT-
PCR on oropharyngeal ﬂuid and faeces samples
were also negative. Furthermore, no viral RNA,
as determined by RRT-PCR, was detected in the
tonsils.
3.1.2. Paderborn low inoculation dose
None of the pigs inoculated with a dose of
102 TCID50 became infected. This was deter-
mined by the absence of clinical symptoms,
fever, leukopenia, viraemia, and antibodies in
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Table I. Clinical symptoms, blood parameters, serology, virus isolation and RRT-PCR results.
Virus strain and dosea CSb Feverc Leukopeniad VI leukocytese ELISAf NPLA titreg RRT-PCR on tonsils
Zoelen – 105 TCID50
I no no yes 5–7 + 640 +
I no no no 5–7 + 320 +
I no no yes 5–7 + 320 +
Paderborn middle – 103.5 TCID50
I yes no yes 7–12 + 80 +
I yes yes yes 5–23 + 20 +
I yes yes yes 5–35 + < 5 +
C yes yes yes 17–35 + < 5 +
C yes yes yes 14–35 + 5 +
C yes yes yes 12–35 + < 5 +
C yes yes yes 17–29 + 20 +
C yes yes yes 14–35 + < 5 +
C yes yes yes 14–35 + < 5 +
C yes yes yes 17–28 + 80 +
Paderborn high – 105 TCID50
I yes yes yes 5–32  < 5 +
I yes yes yes 3–21 + 20 +
I yes yes yes 3–21  < 5 +
C yes yes yes 17–35 + 10 +
C yes yes yes 17–35 + < 5 +
C yes yes yes 17–35 + < 5 +
C yes yes yes 17–24 + 80 +
C yes yes yes 14–21 + 20 +
C yes yes yes 10–35  < 5 +
C yes yes yes 14–31 + 5 +
Brescia – 102.5 TCID50
I yes yes yes 3–14 + < 5 +
I yes yes yes 3–13  < 5 +
I yes yes yes 3–11  < 5 +
C yes yes yes 10–21 + < 5 +
C yes yes no 10–13  < 5 +
C yes yes yes 10–14  < 5 +
C yes yes yes 10–21 + < 5 +
C yes yes yes 10–18 + < 5 +
C yes yes yes 10–13  < 5 +
C yes yes yes 10–12  < 5 +
 Day of death or euthanasia (p.i.).
a Contact pigs of the Zoelen trial and pigs from the Paderborn low inoculation dose trial were not included in the
table since none of the tests showed a positive result.
b Clinical symptoms: CS > 2.
c Body temperature for 2 or more consecutive days > 40 C.
d Leukopenia: < 10 · 109 leukocytes/L blood.
e Interval in days p.i. when virus isolation on leukocytes were positive.
f ELISA on serum samples: + positive,  negative.
g NPLA-titre in serum samples.
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the serum. The virus isolation and RRT-PCR on
oropharyngeal ﬂuid and faeces samples were
also negative. No viral RNA, as determined
by RRT-PCR, was detected in the tonsils. As
a consequence, no virus transmission to the
contact pigs was observed either.
Table II. Infectious virus titres in oropharyngeal ﬂuid (Log10 TCID50/mL), in grey RRT-PCR positive
samples.
Days post-inoculation Virus 
strain/ 
dosea 0 3 4 5 6 7 8 10 11 12 13 14 15 17 19 21 24 26 28 31 33 35 
Zoelen − 105 TCID50
I  − −b 1.9c 3.4 2.7 2.9 − − 1.4 − − − − − − − − − − − − − 
I  − 1.7 3.2 2.9 3.7 3.2 − − − − − − − − − − − − − − − − 
I   − − − − − 0.9 − − 2.4 2.2 − − − − − − − − − − − − 
Paderborn middle − 103.5 TCID50
I  −  − − − − 1.1 − − 3.1 − − − − − − − − − − − − − 
I  −  − − − − 2.1 − − 4.6 0.4 − − − 5.9 4.7 − †
I   −  − − 0.9 − 2.4 − 0.4 5.1 4.7 6.4 7.4 6.4 6.9 4.4 − 4.7 6.4 5.7 4.7 6.7 6.4 
C  −  − − − − − − − − − − − − 2.4 − − 5.2 5.4 4.9 5.9 5.9 7.2 
C  −  − − − − − − − 0.4 − − 1.9 − 2.7 − − 5.2 4.9 4.2 4.4 5.4 6.9 
C  −  − − − − − − − 0.6 − − − − 4.4 − − 5.9 6.9 6.4 3.7 4.9 6.9 
C  −  − − − − − − − − − − − − 2.4 1.7 − 4.7 6.9 6.4 †
C  −  − − − − − − − − − − − − 3.7 2.9 − 5.2 5.9 4.7 4.9 5.2 6.2 
C  −  − − − − − − − − − − − − 2.2 − − 5.7 6.4 6.9 5.7 5.9 6.9 
C  −  − − − − − − − − − − − − 3.2 − 1.2 1.9 3.4 0.4 − 0.9 0.4 
Paderborn high − 105 TCID50
I − − 0.4 0.9 0.6 − − − 5.4 5.1 − − 1.4 5.7 1.4 4.4 5.9 6.2 5.2 4.1 †
I  −
−
− − 0.9 − − − − 3.9 3.4 − − − 4.4 − − − 2.2 4.9 − − − 
I   − 1.6 2.4 − − − − 5.4 4.1 2.1 − 2.1 5.9 2.9 †
C  − − − − − − − − − − − − − − − 5.4 5.2 6.4 4.2 6.2 7.4 7.2 
C  − − − − − − − − − 0.4 − − − 2.2 − − 3.4 3.1 3.7 5.9 6.7 6.9 
C  − − − − − − − − − − − − − − − 0.4 2.6 4.9 4.4 6.4 4.9 6.4 
C  − − − − − − − − − 2.4 − − − − − − − − − − − − 
C  − − − − − − − − 0.4 − − − − − − − − − − − − − 
C  − − − − − − − − − 0.4 − − − 3.2 2.4 5.2 5.9 6.9 6.7 6.9 6.7 7.4 
C  − − − − − − − − − 0.4 − − − − 0.6 4.4 5.2 6.7 6.2 †
Brescia − 102.5 TCID50
I  − 2.9 3.4 3.7 3.9 4.2 3.9 3.7 5.2 4.9 3.9 − †
I  − 3.2 3.2 3.2 3.2 2.2 − 4.7 5.7 5.4 5.7 †
I   − 2.9 2.9 3.7 4.2 − 3.9 5.2 6.2 †
C  − − − − − − − 1.7 5.2 4.7 4.9 − 4.4 5.7 4.9 2.4 †
C  − − − − − − − − 3.9 1.9 3.9 †
C  − − − − − − − 2.4 4.4 2.2 4.4 − †
C  − − − − − − 1.9 2.7 4.7 4.9 3.2 3.9 1.6 5.7 5.4 4.9 †
C  − − − − − − 2.4 − 2.4 2.4 4.2 − 3.2 3.7 †
C  − − − − − − − − 4.9 5.4 3.7 †
C  − − − − − − − 2.4 5.2 4.2 † †
a Contact pigs of the Zoelen trial and pigs from the Paderborn low inoculation dose trial werenot included in
the table since none of these pigs were infected.
b RRT-PCR positive samples are indicated in grey. 
c Log10 TCID50/mL.
−  No virus was isolated. 
† Death or euthanasia of the pig. 
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3.1.3. Paderborn middle inoculation dose
All pigs inoculated with a dose of 103.5
TCID50 became infected and developed clinical
symptoms, leukopenia, viraemia, E2-antibodies
(ELISA) and were RRT-PCR positive in the
tonsils. Infectious virus was detected in oropha-
ryngeal ﬂuid and faeces from day 5 p.i. A wide
variety of clinical symptoms were observed in
these pigs. Two pigs showed severe clinical
Table III. Infectious virus titres in faeces (Log10 TCID50/g), in grey RRT-PCR positive samples.
Days post-inoculation Virus 
strain/ 
dosea 0 3 4 5 6 7 8 10 11 12 13 14 15 17 19 21 24 26 28 31 33 35 
Zoelen − 105 TCID50 
I  − − − − −b − − − − − − − − − − − − − − − − − 
I  − − − − − − − − − − − − − − − − − − − − − − 
I   − − − − − 1.4c − − − − − − − − − − − − − − − − 
Paderborn middle − 103.5 TCID50 
− − − − − − − 2.9 2.9 3.4 2.9 − − − − − − − − − − − − − 
I  − − − 1.6 4.2 5.4 4.7 5.9 5.7 5.7 6.2 5.7 5.9 5.4 4.9 4.9 †     
I   − − − 1.6 3.9 5.7 5.2 6.4 6.7 5.9 6.7 5.9 4.6 5.2 4.4 4.7 6.4 5.2 5.7 4.6 6.1 6.4 
C  − − − − − − − − − − − − − − 1.6 1.6 5.4 4.9 5.7 5.4 4.4 3.9 
C  − − − − − − − − − − − − − − 3.4 4.7 5.2 4.4 3.9 5.9 tox 6.4 
C  − − − − − − − − − 3.2 3.2 4.4 3.4 3.4 3.4 4.2 4.2 3.7 3.7 3.9 tox 5.4 
C  − − − − − − − − − − − − − − 4.7 5.9 4.9 5.2 5.9 †  
C  − − − − − − − − − − − 2.9 3.7 3.4 4.2 4.9 3.9 6.4 3.6 5.7 5.2 4.9 
C  − − − − − − − − − − − − − 4.2 4.7 6.7 6.4 6.2 4.9 4.6 4.7 4.9 
C  − − − − − − − − − − − − − 3.7 3.9 4.4 3.4 3.4 3.4 2.9 3.2 3.7 
Paderborn high − 105 TCID50 
I  − − toxd 3.3 3.7 4.4 4.7 5.4 5.2 5.4 5.9 6.2 6.2 5.2 3.9 4.5 7.2 5.9 6.2 5.2 †
I  − − − tox 2.7 3.9 4.4 2.9 3.9 − − 2.6 3.2 3.9 4.7 3.9 3.4 4.2 3.9 − − − 
I   − − − − 2.9 3.7 4.7 6.7 6.9 4.2 6.4 3.2 6.0 6.9 5.9 †      
C  − − − − − − − − − − − − − − 4.2 4.4 3.9 5.9 7.3 4.7 4.2 6.2 
C  − − − − − − − − − − − − − 4.2 3.4 4.9 4.9 5.2 5.2 6.0 4.4 5.4 
C  − − − − − − − − − − − − − − 3.9 5.9 5.9 3.9 6.8 4.9 5.9 5.1 
C  − − − − − − − − − − − − − 1.9 4.2 − − − − − − − 
C  − − − − − − − − − − − − − 3.4 − − − − − − − − 
C  − − − − − − − − − − 3.2 3.4 4.9 4.7 4.2 4.4 5.4 4.9 4.7 3.2 3.9 4.4 
C  − − − − − − − − − − − − 3.7 4.2 3.9 5.4 5.9 5.4 5.9 †  
Brescia − 102.5 TCID50 
I  − − − 2.9 3.1 2.9 3.4 5.2 4.9 6.7 5.4 4.5 †         
I  − − 1.6 2.6 2.4 3.1 3.7 4.7 4.4 4.4 4.4 †          
I   − − − 1.6 4.1 4.7 2.9 3.9 5.7 †            
C  − − − − − − − 3.9 4.8 4.7 4.4 5.5 5.5 2.7 2.7 4.2 †     
C  − − − − − − − 3.2 4.2 5.2 3.9 †          
C  − − − − − − − 3.4 4.8 4.7 2.7 4.0 †         
C  − − − − − − − 4.9 3.7 5.4 4.7 6.4 4.5 3.9 5.7 4.2 †     
C  − − − − − − − − 3.9 2.7 5.2 3.2 4.4 4.2 †       
C  − − − − − − − 3.4 5.1 4.4 4.4 †          
C  − − − − − − − 3.4 3.7 2.7 †           
− No virus was isolated.
† Death or euthanasia of the pig. 
a
 Contact pigs of the Zoelen trial and pigs from the Paderborn low inoculation dose trial (102TCID50) were not
included in the table since none of these pigs were infected. 
b RRT-PCR positive sample are indicated in grey.
c Log10 TCID50/g. 
d Toxic sample.
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symptoms (CS of 17 and 21), while one pig
showed only mild clinical signs (CS of 3) and
no fever. One inoculated pig died at day 23
p.i. All contact pigs became infected and devel-
oped fever, clinical signs, leukopenia, viraemia
and E2-antibodies. Viral RNA was generally
detected ﬁrst in oropharyngeal ﬂuid and maxi-
mum 7 days later in faeces. In oropharyngeal
ﬂuid, viral RNA was ﬁrst detected either on
day 8 or 10 p.i. Observed clinical signs in the
most severely affected pigs were depression,
loss of appetite, emaciation, increased fre-
quency of breathing, cramps, paralysis of the
hindquarters, inability to stand up, haemorrhag-
es in the skin, and diarrhoea. One contact pig
died at day 29 p.i.
3.1.4. Paderborn high inoculation dose
All pigs inoculated with a dose of 105
TCID50 became infected and developed fever,
clinical symptoms, leukopenia and viraemia.
Infectious virus was detected from day 4 p.i.
in oropharyngeal ﬂuid and from day 5 p.i. in
faeces. Fever started one day earlier than in
the pigs inoculated with the middle dose. Two
inoculated pigs died at days 21 and 32 p.i. Only
the inoculated pig that recovered from the infec-
tion developed E2-antibodies higher than the
cut-off of 30% inhibition. Although the other
two pigs showed an increase in E2-antibody
titre of 19% and 20% inhibition, they died
before the antibody titre could reach the cut-
off. All the contact pigs became infected and
developed fever, clinical symptoms, leukope-
nia, and viraemia. Viral RNA was detected in
oropharyngeal ﬂuid between days 8 and 11
p.i. Six of the seven contact pigs developed
E2-antibodies higher than the cut-off, including
one pig that died at day 31 p.i. The observed
clinical signs in the most severely affected pigs
were comparable to (contacts of) pigs inocu-
lated with the middle dose.
3.1.5. Brescia
All pigs inoculated with the Brescia strain
became infected and developed fever, clinical
signs, leukopenia, and viraemia. Infectious
virus was already detected on the ﬁrst sampling
day (day 3 p.i.) in oropharyngeal ﬂuid. In fae-
ces, infectious virus was detected from day 4
p.i. All inoculated pigs died between days 12
and 15 p.i. One pig developed E2-antibodies
higher than the cut-off, while the E2 ELISA
of one other pig suggests an increase in E2-anti-
bodies (17% inhibition), although the level
remained under the cut-off. The contact pigs
developed fever and clinical signs, and 6 of
the 7 contact pigs developed leukopenia. The
majority of the contact pigs did not develop
E2-antibodies higher than the cut-off. Viral
RNA was detected in oropharyngeal ﬂuid
between days 4 and 6 p.i. All contact pigs died
between days 13 and 22 p.i. The observed clin-
ical signs were severe depression, emaciation,
loss of appetite, cramps, ataxia, inability to
stand up, large haemorrhages in the skin, and
diarrhoea.
3.2. Differences in virus excretion
between strains
All contact infections took place within the
ﬁrst ﬁve days of virus excretion by the inocu-
lated pigs. Figure 1 shows the total virus excre-
tion during these days by the inoculated pigs,
which was expressed by the cumulative excre-
tion (against time). Pigs inoculated with the
Brescia strain excreted the highest amount of
virus in oropharyngeal ﬂuid, but this was only
signiﬁcantly different until the second day of
virus excretion from pigs inoculated with the
middle dose of the Paderborn strain. After the
second day, the differences between the strains
were not signiﬁcant. Pigs inoculated with the
Zoelen strain excreted signiﬁcantly lower
amounts of virus in faeces than pigs inoculated
with the Paderborn and Brescia strain. No sig-
niﬁcant differences in virus excretion in faeces
were observed between pigs inoculated with
the middle dose of the Paderborn strain, the
high dose of the Paderborn strain or the Brescia
strain.
3.3. Quantiﬁcation of transmission parameters
The transmission rate b, the infectious period
Ti, the standard deviation of the infectious period
and the reproduction ratio R0 for all three
Within-pen transmission of CSFV Vet. Res. (2009) 40:59
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assumptions on the infectiousness of pigs are
shown in Table IV. The b of the Zoelen strain
was estimated to be 0 per day, since no virus
transmission occurred. The b of the Paderborn
middle inoculation dose was slightly higher than
that of the Paderborn high inoculation dose,
although the difference was only signiﬁcant
when the infectious period was assumed to coin-
cide with virus excretion in faeces and/or oro-
pharyngeal ﬂuid. The b’s of the Paderborn and
Brescia strain were comparable, except under
the assumption that infectiousness coincided
with virus excretion in faeces only. In that case
the b for strain Brescia was signiﬁcantly higher.
The duration of virus excretion Ti was sig-
niﬁcantly higher for both inoculation doses of
the Paderborn strain than for the Zoelen or Bre-
scia strain, independent of the assumptions.
The reproduction ratio R0 of the Zoelen
strain was estimated to be 0 (0–0.925).
For the Paderborn strain, the R0 was signiﬁ-
cantly higher when the middle dose (148
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Figure 1. Total virus excretion (cumulative virus excretion (against time)) of the three inoculated pigs in
faeces and oropharyngeal ﬂuid until the second day (white bar), third day (grey bar), fourth day (striped bar)
or ﬁfth day (black bar) of virus excretion (depending on strain and sample type, the ﬁrst day of virus
excretion was observed between days 3 and 5 p.i.). a,b: Bars of the same colour with no common letter
differ signiﬁcantly (p < 0.05). Error bars represent standard error of the mean (SEM).
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(53.8–382)) was used for inoculation instead of
the high dose (35.9 (14.5–77.6)), under the
assumption that infectiousness coincided with
virus excretion in faeces and/or oropharyngeal
ﬂuid. The R0 was also signiﬁcantly higher for
the middle dose of the Paderborn strain than
for the Brescia strain (17.5 (7.13–36.9)). Under
the other assumptions, there were no signiﬁcant
difference between both inoculation doses of
the Paderborn strain or the Brescia strain.
4. DISCUSSION
This study quantiﬁed transmission parame-
ters of three strains of different virulence; a
low, moderately and highly virulent strain.
The transmission parameters were estimated
using the maximum likelihood estimation
method, which takes into account the time
course of the experimental epidemic. Different
assumptions were used to determine the period
of infectiousness. These assumptions turned out
to be rather crucial in estimating the transmis-
sion parameters b and R0.
Transmission parameters of moderately viru-
lent strains like the Paderborn strain have been
quantiﬁed with the maximum likelihood esti-
mation method before. For the Paderborn strain,
a b of 0.65 per day (0.40–1.1) was estimated by
Klinkenberg1. Using the same method Klinken-
berg applied, we actually found the same b of
0.65 per day (0.37–1.1) for the Paderborn strain
with the data of our study (results not shown).
Table IV. Estimation of transmission parameters with 95% conﬁdence intervals, based on different
assumptions on the infectious period of pigs.
Transmission parameter Virus strain and inoculation dose1
Zoelen
– 105 TCID50
Paderborn middle
– 103.5 TCID50
Paderborn high
– 105 TCID50
Brescia
– 102.5 TCID50
b (day1)
Assumption 1 (faeces)2 0c (0–2.74) 5.38b (2.11–12.2) 2.83b,c (1.17–5.84) 27.5a (10.2–63.0)
Assumption 2 (OPF/faeces)3 0c (0–0.144) 5.38a (2.11–12.2) 1.62b (0.685–3.23) 2.07a,b (0.881–4.05)
Assumption 3 (viraemia)4 0b (0–0.203) 3.23a (1.33–6.74) 1.14a (0.486–2.24) 3.00a (1.27–5.96)
Ti (day)
Assumption 1 (faeces) –5 (– – –) 26.2a (17.4–42.6) 21.2a (13.4–34.5) 7.39b (5.54–9.99)
Assumption 2 (OPF/faeces) 6.33b (4.69–8.69) 27.5a (18.4–43.7) 22.2a (16.2–31.9) 8.47b (6.17–11.8)
Assumption 3 (viraemia) – (– – –) 24.4a (17.5–36.8) 21.8a (16.7–30.3) 8.38b (6.34–11.2)
SD6 of Ti (day)
Assumption 1 (faeces) – (– – –) 12.8a (7.33–21.6) 13.0a (8.14–20.9) 3.22b (2.15–5.67)
Assumption 2 (OPF/faeces) 1.23b (0.648–3.82) 13.2a (7.63–21.8) 9.32a (5.81–16.5) 4.06b (2.71–7.11)
Assumption 3 (viraemia) – (– – –) 10.6a (6.27–18.9) 7.99a (4.90–14.8) 3.54b (2.36–6.13)
R0
Assumption 1 (faeces) – (– – –) 141a (50.6–367) 60.0a (22.5–145) 203a (73.2–488)
Assumption 2 (OPF/faeces) 0c (0–0.925) 148a (53.8–382) 35.9b (14.5–77.6) 17.5b (7.13–36.9)
Assumption 3 (viraemia) – (– – –) 78.8a (30.7–181) 24.8a (10.2–52.0) 25.1a (10.3–52.8)
a–c Means within rows with no common superscript differ signiﬁcantly.
1 Pigs from the low inoculation dose trial (102 TCID50) were not included in the table since none of the pigs were
infected.
2 Start and end of the infectious period coincided with virus excretion in faeces.
3 Start and end of the infectious period coincided with virus excretion in faeces and/or oropharyngeal ﬂuid.
4 Start and end of the infectious period coincided with viraemia.
5 The 95% interval could not be determined due to lack of (variation in) data.
6 Standard deviation.
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This shows that the estimation of the b for the
same strain is reproducible, when using the
same assumptions. For our study, different
observations were used to determine transmis-
sion parameters, which will be discussed in
more detail below.
First of all, we used another matrix (oropha-
ryngeal ﬂuid instead of blood) and diagnostic
tool (RRT-PCR instead of VI) to determine the
moment of infection of contact pigs. Using oro-
pharyngeal ﬂuid instead of blood as a matrix
seems biologically more appropriate, since the
virus replicates ﬁrst in the tonsil and pharyngeal
region, after which it spreads throughout the
body.Viraemiaoccurs at a later stageof the infec-
tion at a moment when secretions from the oro-
pharyngeal region can already contain
infectious virus [28]. The use of the RRT-PCR
instead of the virus isolation will improve the
determination of the moment of infection of the
contact pigs, since the RRT-PCR has a higher
sensitivity than virus isolation [6, 18, 26].
Between pigs infected with the same strain,
smaller differences exist in the moment after
infection that the RRT-PCR on oropharyngeal
swabs becomes positive than the virus
isolation on blood samples is positive [24, 28]
(this study).
Secondly, the start of the infectious period of
pigs was determined by the ﬁrst detection of
infectious virus in faeces, oropharyngeal ﬂuid
or leukocytes (viraemia). The presence of infec-
tious virus in secretions and excretions might be
a better indicator of infectiousness of the pig than
viraemia, since virus excretion may not coincide
with viraemia [28]. In the present study, we used
faeces and oropharyngeal ﬂuid. Faeces are
excreted in large amounts in the environment
and may be the main source of infectious virus
from an infected pig [28]. However, especially
in the ﬁrst days after infection, when virus can-
not yet be detected from faeces, virus from other
secretions and excretions, like from the oronasal
region, may contribute in a relevant way to virus
transmission as well. In the present study, oro-
pharyngeal ﬂuid was used as a matrix to detect
virus ﬁrst, based on previous studies [28]. How-
ever, it cannot be excluded that virus excretion
occurs even earlier in other secretions not tested
in this experiment.
Differences were observed between the
strains in b. The b of the Paderborn strain and
Brescia strain were always signiﬁcantly higher
that the b of the Zoelen strain. The pigs inocu-
lated with the Zoelen strain did not transmit the
virus to the contact pigs at all. This was not
expected since this strain was isolated in 1975
from foetuses of a ‘‘carrier sow’’ during a ﬁeld
outbreak2. In several experimental studies3
[28], virus titres in blood and secretions and
excretionswere always low,which could explain
the inability of this strain to transmit to contact
pigs in the present experiment. This strain was,
however, successful in transplacental transmis-
sion [5]. Persistently infected piglets, excreting
high quantities of virus, might have been a way
for this strain to maintain itself in the ﬁeld.
Besides, this strain has been cell passaged before
inoculation of the pigs in the present experiment,
which could also have reduced the virulence.
Between the Paderborn and Brescia strains,
the difference in b depended on the assump-
tions on the start and duration of the infectious
period of the pigs. Assuming that biologically
the most appropriate way to determine whether
a pig is infectious, is the detection of infectious
virus from faeces and/or oropharyngeal ﬂuid,
no signiﬁcant differences between the Pader-
born and Brescia strains in b (and virus excre-
tion) were observed. These results were not
unexpected. In a previous study on virus excre-
tion, it was shown that CSFV excretion is
dependent on the strain and the clinical appear-
ance of infection [28]. In the group of pigs
infected with the Paderborn strain, both chroni-
cally and acutely infected pigs were observed.
Together, these pigs did not excrete amounts
2 Van Oirschot J.T., Congenital infections with a
moderately virulent swine fever virus. Persistent
and inapparent infections with swine fever virus of
low virulence. Their effects on the immune system,
Ph.D. thesis University of Utrecht, The Nether-
lands, 1980, pp. 114–119.
3 Van Oirschot J.T., Comparison of virulence of
three ﬁeld isolates of swine fever virus. Persistent
and inapparent infections with swine fever virus of
low virulence. Their effects on the immune system,
Ph.D. thesis University of Utrecht, The Nether-
lands, 1980, pp. 120–125.
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of virus that were signiﬁcantly different from
pigs infected with the Brescia strain during
the ﬁrst ﬁve days of excretion, in which period
all transmission events occurred (this study).
Comparable excretion patterns therefore seem
to result in comparable transmission rates for
CSF, at least in the early infectious period. Fur-
ther research using one-to-one experiments,
with single infectious pigs housed with single
susceptible pigs, could further clarify the corre-
lation between the level of virus excretion and
transmission.
When the infectious period was assumed to
coincide with virus excretion in faeces and/or
oropharyngeal ﬂuid, the R0 of the Paderborn
strain (middle dose) was signiﬁcantly higher
than the R0 of the Brescia strain. However,
for strains with R0-values signiﬁcantly higher
than 1, the generation interval is also an impor-
tant measure in the initial phase of the outbreak
[27]. The generation interval is the time
between the infection moment of a pig and
the moment of ﬁrst infection of a contact animal
by this pig. For the Paderborn strain this gener-
ation interval was 5 to 8 days, and for the Bre-
scia strain 3 to 5 days, which would lead to
exponential growth rates of 0.3/day (Paderborn)
and 0.4/day (Brescia) in the initial phase of the
outbreak [11]. So even though the Paderborn
strain has a higher R0 than the Brescia strain,
the growth rate of the latter strain was higher
due to its shorter generation interval.
The different doses of the Paderborn strain
used for inoculation resulted in differences in
transmission. The low dose of 102 TCID50 was
not high enough to result in infection of even
one of the three inoculated pigs. This was not
expected since a slightly higher dose of 102.5
TCID50 of the Paderborn strain resulted in
infection of 4 of 5 inoculated pigs1. A higher b
was observed with the middle inoculation dose
than with the high dose. However, in subsequent
generations, this difference will most likely dis-
appear since there were no differences in the
moment contact pigs were infected, or amounts
of virus excreted by the inoculated pigs.
In conclusion, the different assumptions
regarding the infectiousness of pigs resulted in
differences in b and R0. It was concluded that
biologically the most appropriate assumption
is where infectiousness coincides with virus
excretion in faeces and/or oropharyngeal ﬂuid.
Under this assumption it was noteworthy that
b’s were comparable for a moderately and
highly virulent strain and that differences in
transmission between these strains depend
therefore on a different length of the infectious
period and the length of the generation interval.
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